Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction. - Wikidata - awgldk - TriplyDB

Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction.

Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction.

http://www.wikidata.org/entity/Q33533540

about

Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity Anti-Apolipoprotein A-1 IgG Predict All-Cause Mortality and Are Associated with Fc Receptor-Like 3 Polymorphisms.Definition of human apolipoprotein A-I epitopes recognized by autoantibodies present in patients with cardiovascular diseases.IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study.The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?Anti-apolipoprotein A-1 IgG levels predict coronary artery calcification in obese but otherwise healthy individuals.Autoantibodies to apolipoprotein A-1 in cardiovascular diseases: current perspectives.Auto-antibodies as emergent prognostic markers and possible mediators of ischemic cardiovascular diseases.Biomarkers for cardiovascular risk assessment in autoimmune diseases.Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes.Cardiovascular risk in patients with rheumatoid arthritis.ApoA1 and ApoA1-specific self-antibodies in cardiovascular disease.Unmet Needs in the Pathogenesis and Treatment of Systemic Lupus Erythematosus.Anti-apolipoprotein A-1 antibodies and carotid intima-media thickness in Egyptian women with systemic lupus erythematosus.Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?Anti-apolipoprotein A-1 autoantibodies as biomarker for atherosclerosis burden in patients with periodontitis.Pharmacological Intervention to Modulate HDL: What Do We Target?Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex.Autoantibodies against apolipoprotein A-1 and phosphorylcholine for diagnosis of non-ST-segment elevation myocardial infarction.The Contribution of Autoantibodies to Inflammatory Cardiovascular Pathology.Diagnostic and prognostic value of autoantibodies anti-apolipoprotein A-1 and anti-phosphorylcholine in acute non-ST elevation myocardial infarction Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability

P2860

Q27004493-60BB6F3A-D016-46A9-B3C2-12A6CBCFCE36 Q33573479-837C4C6C-90FF-447E-9921-46B116D6A2AB Q34317326-176965B3-4EE2-46DB-B74C-CB9AB4A3354D Q35162593-2F95970D-C4F5-43F9-BC13-6FDFCB3255F8 Q35692746-C6DB4FA8-42F6-42D2-B4A2-E796BC1B0FD9 Q36431826-17DE2774-EFDF-47CC-9263-4E748548AF1F Q36438919-5DE9C66E-B05F-4C0B-BB03-F0E9BC8DA793 Q37824302-40202E66-9F47-411A-B839-E2278219F212 Q38293735-9C661210-7131-4D7D-B4D9-C4960415ED34 Q38753862-25C19AB8-BA08-40F0-A56C-8B04696D36D2 Q38813397-0702613C-7C0F-454E-9B26-B8796C2ED67B Q38835289-7DAC4BCA-0EC6-4C22-A8BE-84B3C19606FE Q39150632-73716820-2E07-4384-896D-03520FFC033F Q39377043-0A3A1A34-96B8-4FCE-922C-B273AADAF576 Q43832641-489B4023-CD61-4DA2-AB94-E7DFD86F9846 Q45346743-4FA1D2D0-F7D2-44FB-A943-59605D3DEBDB Q49554117-44D9FCFA-F262-4555-9BE4-B25E9A0904A2 Q50104271-81FA7C82-58CA-4555-9731-FDEA1CA88593 Q50253399-CA060E12-C0E0-4309-82F3-1C41556B8AAC Q51503137-EC3E4886-E8CC-4D02-BC3B-C5DBA107AA78 Q55318081-0F3A5964-4F35-40BA-9D48-CEA64D7AAD97 Q58197552-98B27E69-5CCF-4B46-8A13-BAB3F6D00AD3 Q58197642-9422BC9F-1C29-4333-A9C5-34435BC682EA

P2860

Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction.

http://www.wikidata.org/entity/Q33533540

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Anti-apolipoprotein A-1 IgG as ...... rate in myocardial infarction.

@ast

Anti-apolipoprotein A-1 IgG as ...... rate in myocardial infarction.

@en

Anti-apolipoprotein A-1 IgG as ...... rate in myocardial infarction.

@nl

type

label

Anti-apolipoprotein A-1 IgG as ...... rate in myocardial infarction.

@ast

Anti-apolipoprotein A-1 IgG as ...... rate in myocardial infarction.

@en

Anti-apolipoprotein A-1 IgG as ...... rate in myocardial infarction.

@nl

prefLabel

Anti-apolipoprotein A-1 IgG as ...... rate in myocardial infarction.

@ast

Anti-apolipoprotein A-1 IgG as ...... rate in myocardial infarction.

@en

Anti-apolipoprotein A-1 IgG as ...... rate in myocardial infarction.

@nl

P1433

Q33533540-0BE398F3-92A7-4174-8A5B-5CA9D913BFC2

P1476

Q33533540-7EB40BC9-F647-4919-967A-744D129E0D65

P2093

Q33533540-017FC3EF-A31A-4898-A1E7-3A5F22C7643B

Q33533540-0E82F90B-8F64-4861-9F9E-61C02587B7EE

Q33533540-1FDBBC5F-40A8-46B4-B725-72F093334CEB

Q33533540-3107F838-8AB4-4816-8097-3883AF13CC89

Q33533540-70D49D54-9DC3-4B9A-93AF-608FC3F8CC46

Q33533540-91A0BA6C-6606-4922-998F-AEC6223E3D51

Q33533540-BEC3FD77-0E5C-431E-B3A4-2CB977BBD9B7

Q33533540-CA001781-C99E-45B9-AEB7-55E21EE523AE

Q33533540-D88E51A5-7E58-466E-91D1-1A4F63EBDB06

Q33533540-F52659C9-16F7-4B6E-9D4B-CCB5127D834E

P2860

Q33533540-000B7B2A-6E4E-4A78-8040-49419F8D6FB7

Q33533540-084715F9-B307-4BC5-88F6-2728DA1F43F3

Q33533540-2922E9E1-1C47-4A70-99B8-F8A08115AB72

Q33533540-2DBBBABE-9A2D-4195-A768-FF0FA8397A37

Q33533540-427E9568-E9FF-4A95-A9A6-5E3F6ED8E601

Q33533540-5949580F-B808-43E9-B781-C37F3D35EB47

Q33533540-62F9E9A1-6EAF-474D-B683-30CF5CB18D72

Q33533540-63141AC8-7BC2-4066-AB57-DD1F7E240AE0

Q33533540-6C6EC852-E7FA-4B35-9393-D13EB5B4BF14

Q33533540-6E6FCF9A-1D52-4538-BF54-864AF8789CC4

P304

Q33533540-2D1FBE06-9B39-4D04-BA61-D42144FA17BB

P31

Q33533540-120841EB-C697-4B69-BAC7-43066401E2C4

P356

Q33533540-A3044F2A-2DB3-4FE2-B95D-BD11AA3F5001

P433

Q33533540-C20C5DF3-4E10-4125-856A-5088EF5D3946

P478

Q33533540-0E470372-9A2E-4823-9D4B-9197DB0BD8AA

P577

Q33533540-5EF5DB7C-5CC5-4F2D-8033-2160CE00E4F8

P5875

Q33533540-311B145D-2B97-4DA7-BBB2-40B504B99E64

P698

Q33533540-44EE4D44-F2BC-40A2-A77F-6A042D214563

P921

Q33533540-54838EF5-FD41-465C-A58D-9E9B8EDFCF66

Q33533540-D7807C7A-B4B8-4E6A-AD3F-3C5E937224E9

P356

P1433

European Heart Journal

P1476

Anti-apolipoprotein A-1 IgG as ...... rate in myocardial infarction.

@en

P2093

Emmanuel Charbonney

http://www.w3.org/2001/XMLSchema#string

François Mach

http://www.w3.org/2001/XMLSchema#string

Guido Reber

http://www.w3.org/2001/XMLSchema#string

Magaly Python

http://www.w3.org/2001/XMLSchema#string

Michel F Rossier

http://www.w3.org/2001/XMLSchema#string

Nicolas Vuilleumier

http://www.w3.org/2001/XMLSchema#string

Pascale Roux-Lombard

http://www.w3.org/2001/XMLSchema#string

René Nkoulou

http://www.w3.org/2001/XMLSchema#string

Richard James

http://www.w3.org/2001/XMLSchema#string

Sabrina Pagano

http://www.w3.org/2001/XMLSchema#string

P2860

Role of the T-type calcium channel CaV3.2 in the chronotropic action of corticosteroids in isolated rat ventricular myocytes

Inflammation in atherosclerosis

Corticosteroids and redox potential modulate spontaneous contractions in isolated rat ventricular cardiomyocytes.

Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST).

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial.

Autoantibody-mediated atherosclerosis.

Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association.

Is the failing heart energy starved? On using chemical energy to support cardiac function.

Role of T-type Ca2+ channels in the heart.

Mechanisms of disease: atherosclerosis in autoimmune diseases.

P304

815-823

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHQ055

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41532209

http://www.w3.org/2001/XMLSchema#string

P698

20176799

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio